Literature DB >> 10698342

Expression of the anaphylatoxin C5a receptor in non-myeloid cells.

J Zwirner1, A Fayyazi, O Götze.   

Abstract

C5, a 74 amino acid peptide cleaved from the complement protein C5, represents the most potent anaphylatoxin and possesses inflammatory as well as immunomodulatory activities. In the past, expression of the receptor for the anaphylatoxin C5a (C5aR) has been thought to be restricted to cells of myeloid origin. However, recent evidence suggests that the C5aR is constitutively expressed in non-myeloid cells including epithelial, endothelial and smooth muscle cells in the human liver and lung. These findings are contrasted by results from our laboratory which demonstrated that in the normal human liver and lung C5aR expression is detectable exclusively in macrophages and macrophage-derived cells (Kupffer cells). Interestingly, we found evidence that C5aR expression may be inducible in epithelial cells as C5aR mRNA was observed in vivo in human keratinocytes of the inflamed but not of the normal skin. Herein we review the work of our laboratory and others on the expression of the C5aR in various human non-myeloid cells types. A better understanding of the expression patterns of this important anaphylatoxin receptor may provide new insights in the pathophysiological role of C5a in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10698342     DOI: 10.1016/s0161-5890(99)00109-1

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  23 in total

Review 1.  Complement in central nervous system inflammation.

Authors:  Scott R Barnum
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Getting over our Immune-Complex - C5a receptor blockade is the answer.

Authors:  Joshua M Thurman
Journal:  Cell Mol Immunol       Date:  2015-07-06       Impact factor: 11.530

Review 3.  Immunological effects and therapeutic role of C5a in cancer.

Authors:  Victoria R Darling; Ralph J Hauke; Stefano Tarantolo; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2014-11-12       Impact factor: 4.473

4.  Targeting the minor pocket of C5aR for the rational design of an oral allosteric inhibitor for inflammatory and neuropathic pain relief.

Authors:  Alessio Moriconi; Thiago M Cunha; Guilherme R Souza; Alexandre H Lopes; Fernando Q Cunha; Victor L Carneiro; Larissa G Pinto; Laura Brandolini; Andrea Aramini; Cinzia Bizzarri; Gianluca Bianchini; Andrea R Beccari; Marco Fanton; Agostino Bruno; Gabriele Costantino; Riccardo Bertini; Emanuela Galliera; Massimo Locati; Sérgio H Ferreira; Mauro M Teixeira; Marcello Allegretti
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

Review 5.  Anaphylatoxins: their role in bacterial infection and inflammation.

Authors:  Pieter-Jan Haas; Jos van Strijp
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

6.  Targeting complement component 5a promotes vascular integrity and limits airway remodeling.

Authors:  Mohammad A Khan; Christian Maasch; Axel Vater; Sven Klussmann; John Morser; Lawrence L Leung; Carl Atkinson; Stephen Tomlinson; Peter S Heeger; Mark R Nicolls
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

Review 7.  Complement components as potential therapeutic targets for asthma treatment.

Authors:  Mohammad Afzal Khan; Mark R Nicolls; Besiki Surguladze; Ismail Saadoun
Journal:  Respir Med       Date:  2014-01-15       Impact factor: 3.415

8.  Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage.

Authors:  M Fung; M Lu; H Fure; W Sun; C Sun; N Y Shi; Y Dou; J Su; X Swanson; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

9.  Increased C5a receptor expression in sepsis.

Authors:  Niels C Riedemann; Ren-Feng Guo; Thomas A Neff; Ines J Laudes; Katie A Keller; Vidya J Sarma; Maciej M Markiewski; Dimitrios Mastellos; Christoph W Strey; Carl L Pierson; John D Lambris; Firas S Zetoune; Peter A Ward
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

10.  Up-regulation of C5a receptor expression and function on human monocyte derived dendritic cells by prostaglandin E2.

Authors:  Oliver Weinmann; Ralf Gutzmer; Jörg Zwirner; Miriam Wittmann; Katja Langer; Margarete Lisewski; Susanne Mommert; Alexander Kapp; Thomas Werfel
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.